BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 25270198)

  • 1. [CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].
    Wu Y; Liang L; Shi G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1009-12. PubMed ID: 25270198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
    Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
    J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
    Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
    Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
    J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The protective role of peroxisome proliferator activated receptors-α and pathomechanism in D-galactosamine/lipopolysaccharide- induced acute liver failure in rats].
    Jiao M; Ren F; Zhou L; Duan Z; Zhao C
    Zhonghua Nei Ke Za Zhi; 2014 Sep; 53(9):730-4. PubMed ID: 25511408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
    Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
    J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of histamine H1 receptor and H2 receptor in LPS-induced liver injury.
    Masaki T; Chiba S; Tatsukawa H; Noguchi H; Kakuma T; Endo M; Seike M; Watanabe T; Yoshimatsu H
    FASEB J; 2005 Aug; 19(10):1245-52. PubMed ID: 16051691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
    Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
    Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.
    Yan D; Liu HL; Yu ZJ; Huang YH; Gao D; Hao H; Liao SS; Xu FY; Zhou XY
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of alpha-calcitonin gene-related peptide induces inflammatory responses and lethality in sepsis.
    Lee JK; Jung JS; Park SH; Sim YB; Suh HW
    Cytokine; 2013 Nov; 64(2):548-54. PubMed ID: 24021706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of neutrophils in treatment of rats with D-galactosamine-induced acute liver failure with bone marrow mesenchymal stem cells].
    Zhao X; Shi XL; Zhang ZH; Ma HC; Yuan XW; Ding YT
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):601-607. PubMed ID: 27788708
    [No Abstract]   [Full Text] [Related]  

  • 12. Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation.
    Li X; Gou C; Yang H; Qiu J; Gu T; Wen T
    Scand J Gastroenterol; 2014 Aug; 49(8):993-1000. PubMed ID: 24797709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective effect of germanium-containing Spirulina in rats with (D)-galactosamine- and lipopolysaccharide-induced hepatitis.
    Yoshinari O; Shiojima Y; Igarashi K
    Br J Nutr; 2014 Jan; 111(1):135-40. PubMed ID: 23768655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of antibodies against high-mobility group box 1 and tumor necrosis factor-α antibodies on D-(+)-galactosamine hydrochloride/lipopolysaccharide-induced acute liver failure.
    Wang W; Sun L; Deng Y; Tang J
    FEBS J; 2013 Mar; 280(6):1409-19. PubMed ID: 23331758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages.
    Li L; Duan C; Zhao Y; Zhang X; Yin H; Wang T; Huang C; Liu S; Yang S; Li X
    Int Immunopharmacol; 2017 Oct; 51():99-106. PubMed ID: 28822324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
    Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
    Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
    Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
    Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
    Akashi I; Kagami K; Hirano T; Oka K
    J Pharm Pharmacol; 2009 Apr; 61(4):473-8. PubMed ID: 19298694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
    Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
    Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.